CTRI/2012/07/002758已完成2 期
eoadjuvant chemotherapy with weekly paclitaxel and carboplatin followed by chemoradiation in locally advanced cervical carcinoma: a pilot study.
Dr BR Ambedkar Institute Rotary Cancer Hospital0 个研究点目标入组 20 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Female patients of age between 18 and 70 years and performance status ECOG 0-2 .
- •Squamous cell carcinoma and adenocarcinoma of cervix with histologically confirmed FIGO Stage IB2-IVA and bidimensionally measurable lesion.
排除标准
- •Undifferentiated, neuroendocrine, small cell carcinoma or rare histologies/ Prior chemotherapy or local therapy/ Significant co-morbid conditions or abnormal haematological or biochemical parameters precluding chemotherapy/ Pregnancy and lactation/ Mental illness/
- •Previous or concomitant malignancies.
研究者
相似试验
已完成
2 期
eoadjuvant chemotherapy with Paclitaxel/Bevacizumab followed by FEC (5-Fluorouracil/Epirubicin/Cyclophosphamide) for triple negative operable primary breast cancerbreast cancerJPRN-UMIN000010228Department of Surgery, Division of Breast and Endocrine Surgery, St. Marianna University School of Medicine20
进行中（未招募）
不适用
eoadjuvant chemotherapywith weekly docetaxel followed from concomitant docetaxel-RT in patients with high risk locally advancedprostate cancer - docrtpchigh risk locally advancedprostate cancerMedDRA version: 9.1Level: LLTClassification code 10060862Term: Prostate cancerEUCTR2008-003525-16-ITISTITUTI FISIOTERAPICI OSPITALIERI
进行中（未招募）
1 期
Preoperative chemotherapy with paclitaxel in women with HER2-negative high-risk breast cancerEUCTR2012-003481-41-ITFONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI632
进行中（未招募）
1 期
Preoperative chemotherapy with paclitaxel in women with HER2-negative high-risk breast cancerEUCTR2012-003481-41-DEFONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI632
进行中（未招募）
1 期
Preoperative chemotherapy with paclitaxel in women with HER2-negative high-risk breast cancerEUCTR2012-003481-41-ATFONDAZIONE MICHELANGELO - AVANZAMENTO DELLO STUDIO E CURA DEI TUMORI632